selenomethionine (SLM) / University of Iowa, The University of Iowa, Holden Comprehensive Cancer Center  >>  Phase 2
Welcome,         Profile    Billing    Logout  

10 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
selenomethionine (SLM) / Holden Comprehensive Cancer Center, The University of Iowa
KLYMF, NCT00455416: Dietary Intervention in Follicular Lymphoma

Unknown status
2
45
Europe
Omega 3 fatty acids (EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid)), Nycoplus omega-3 1000mg, Selenium (L-Selenomethionine),, Solaray selenium 100mcg, Garlic extract (Allicin), Circuline, Pomegranate juice (ellagic acid), Produced by:Tine Meierier., Grape juice (resveratrol, quercetin), Produced by Tine Meierier, Green Tea (Epigallocathechin gallate), Green tea - twinings java green tea
Oslo University Hospital, University of Oslo
Follicular Lymphoma
04/09
12/09
NCT00625183: Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

Terminated
2
5
US
selenomethionine, capecitabine, oxaliplatin, laboratory biomarker analysis, pharmacological study, adjuvant therapy, neoadjuvant therapy, therapeutic conventional surgery, radiation therapy
Roswell Park Cancer Institute, National Cancer Institute (NCI)
Colorectal Cancer
10/09
12/09
NCT00526890: Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Terminated
2
16
US
selenomethionine, carboplatin, paclitaxel, laboratory biomarker analysis, radiation therapy
Roswell Park Cancer Institute
Lung Cancer
08/10
09/10
NCT00935038: Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Active, not recruiting
2
18
US, RoW
selenomethionine, placebo
Roswell Park Cancer Institute
Chemotherapeutic Agent Toxicity, Head and Neck Cancer, Mucositis, Radiation Toxicity, Xerostomia
04/12
 
NCT01682031: Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy

Terminated
2
18
US, RoW
selenomethionine, placebo, PLCB, cisplatin, CACP, CDDP, CPDD, DDP, radiation therapy, irradiation, radiotherapy, therapy, radiation, quality-of-life assessment, quality of life assessment
Roswell Park Cancer Institute, National Cancer Institute (NCI)
Chemotherapeutic Agent Toxicity, Mucositis, Radiation Toxicity, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Xerostomia
04/12
06/12
NCT00736164: Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer

Withdrawn
2
0
US
selenomethionine, placebo
Roswell Park Cancer Institute, National Cancer Institute (NCI)
Prostate Cancer
06/12
 
NCT00736645: Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Completed
2
55
US
selenomethionine, finasteride, placebo
Roswell Park Cancer Institute
Prostate Cancer
12/12
12/12
NCT02302768: Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT

Unknown status
2
60
NA
Selenomethionine, Placebo
University of Siena, IBSA Institut Biochimique SA
Thyroiditis Autoimmune
01/14
01/15
NCT00669656: Herbal Therapy for Treatment of Recurrent Prostate Cancer

Completed
2
43
US
Prostate Health Cocktail, Cholecalciferol, Vitamin D3, d-alpha tocopherol, vitamin E, L-selenomethionine, selenium, green tea extract, EGC, Epigallocatechin, saw palmetto, lycopene, Isoflavanoids, Daidzein, Genisetein
University of Southern California
Prostate Cancer
07/14
10/14
NCT05363631: Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Recruiting
1/2
55
US
Selenomethionine (SLM), Axitinib, Pembrolizumab
Bilal G. Rahim, University of Iowa
Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic
12/26
12/26

Download Options